Caregen Co Ltd

Caregen maintains a strong liquidity position, with a current ratio of 9.92, indicating that it holds significantly more current assets than current liabilities. The company has no long-term debt and holds KRW 8.85 billion in cash and equivalents, further supporting its liquidity profile. However, the company reported negative free cash flow of KRW -10.8 billion in the latest period, driven by capital expenditures of KRW -4.92 billion. In terms of profitability, Caregen delivered a return on equity (ROE) of 9.46% and a return on assets (ROA) of 8.69%, both of which exceed the typical thresholds for the pharmaceutical industry. The company's operating margin of 28.0% (calculated as operating income of KRW 20.4 billion on revenue of KRW 72.8 billion) is also robust, suggesting strong cost control and pricing power. Caregen's revenue is concentrated in a single business segment, as disclosed in its financial reporting, with no geographic breakdown provided in the latest available data. This lack of geographic diversification may expose the company to regional regulatory or market risks, though no specific geographic concentration is currently quantified in the data. The company's growth trajectory is positive, with revenue of KRW 72.8 billion in the latest period. While no forward-looking revenue guidance is provided, the company's strong operating performance and high ROE suggest a stable growth outlook. The absence of long-term debt and the low dilution risk further support a conservative capital structure. Caregen's risk profile is characterized by low liquidity and dilution risk, with no immediate filing-based flags detected. The company has not issued new shares in the latest period, and its diluted share count remains unchanged at 48.87 million shares. No recent regulatory or legal events have been disclosed in the latest filings, and the company appears to be in a stable operational phase. No recent earnings call transcripts or 10-K filings are available in the current dataset, so no specific recent events or management commentary can be cited at this time.